ÂÜÀòÂÒÂ×

Eric Lev is a General Partner at Ampersand Capital Partners, focusing on growth-oriented healthcare investments since February 2013. In addition to this role, Eric serves as a board member for several organizations, including iuvo BioScience, Biosynth, Alliance Pharma, Leinco Technologies, ALPCO, Interpace Biosciences, Nexelis, Nexcelom Bioscience, and Genoptix, Inc. Eric Lev holds an MBA from The University of Chicago Booth School of Business and a BA in Economics from Northwestern University, complemented by an earlier education at Belmont Hill School.